A REVIEW OF KINASE INHIBITOR-1

The phylogenetic map from the human kinome demonstrating growth and US FDA acceptance of small molecule kinase inhibitors to tyrosine kinases and serine/threonine kinases for various good and hematologic malignancies.Olumiant (baricitinib) - In June 2018, the FDA initially approved Eli Lilly’s Olumiant tablets for use with the treatment of rheuma